Evaluation of Varicella Zoster Virus specific immune response assessed by IFN-g releasing assay
Phase 1
- Conditions
- healthy adult, 20 to 75 years of age
- Registration Number
- JPRN-UMIN000018695
- Lead Sponsor
- The Tazuke Kofukai Medical Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
Vaccination inappropriate person : A person under any of the following condition is not able to be vaccinated. 1. A person who has a fever 2. A person appear suffering severe acute illness 3. A person who previously exhibited anaphylaxis by components of this varicella vaccine 4. A pregnant woman 5. In addition to the persons listed above, a person who is in an inappropriate state for vaccination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of change of IFN-g after vaccination of varicella vaccine
- Secondary Outcome Measures
Name Time Method